Align Technology 과거 순이익 실적
과거 기준 점검 2/6
Align Technology의 수입은 연평균 -11.3%의 비율로 감소해 온 반면, Medical Equipment 산업은 수입이 연평균 13.6% 증가했습니다. 매출은 연평균 2.8%의 비율로 증가해 왔습니다. Align Technology의 자기자본이익률은 10.4%이고 순이익률은 10.5%입니다.
핵심 정보
-11.26%
순이익 성장률
-9.29%
주당순이익(EPS) 성장률
| Medical Equipment 산업 성장률 | 8.90% |
| 매출 성장률 | 2.85% |
| 자기자본이익률 | 10.36% |
| 순이익률 | 10.50% |
| 다음 순이익 업데이트 | 29 Jul 2026 |
최근 과거 실적 업데이트
Recent updates
분석 기사 • May 18
We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...
내러티브 업데이트 • May 12
ALGN: Higher Future Multiple Will Depend On Execution And Elliott Engagement
Narrative Update on Align Technology The updated analyst price target for Align Technology moves to $175.00 from $152.60, with analysts citing a higher assumed future P/E multiple, along with slightly lower modeled revenue growth and profit margins, as key reasons for the change. Analyst Commentary Recent research on Align Technology reflects a mix of optimism and caution, with several firms adjusting price targets and ratings over the past few months.
내러티브 업데이트 • Apr 21
ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst
The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.
내러티브 업데이트 • Apr 07
ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing
The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.Seeking Alpha • Mar 24
Align Technology: Only International Growth Can Save Them Now (Downgrade)
Summary Align Technology (ALGN) is downgraded to a hold as recent share gains have priced in much of the near-term upside. ALGN faces stagnating revenue, declining margins, and potential market share erosion in clear aligners, especially in North America. International markets, particularly Latin America and APAC, offer double-digit volume growth potential, but North American saturation limits overall growth. Strong balance sheet, robust free cash flow, and ongoing buybacks provide stability, but lack of a clear path to double-digit growth tempers enthusiasm. Read the full article on Seeking Alpha내러티브 업데이트 • Mar 23
ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward
Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.내러티브 업데이트 • Mar 08
ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions
The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.내러티브 업데이트 • Feb 22
ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook
Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.내러티브 업데이트 • Feb 08
ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story
Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.내러티브 업데이트 • Jan 25
ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook
Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.내러티브 업데이트 • Jan 10
ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations
Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.분석 기사 • Jan 04
Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...내러티브 업데이트 • Dec 21
ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp
Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.내러티브 업데이트 • Dec 07
ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp
Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.내러티브 업데이트 • Nov 23
ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum
Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.내러티브 업데이트 • Nov 08
ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook
Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.내러티브 업데이트 • Oct 24
Digital Workflow Improvements And Market Weakness Will Shape The Coming Year
Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.내러티브 업데이트 • Oct 10
Emerging Markets And Digital Workflow Will Fuel Future Success
Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.분석 기사 • Jul 17
Align Technology, Inc.'s (NASDAQ:ALGN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Align Technology, Inc. ( NASDAQ:ALGN ) may be sending very bearish...분석 기사 • Jun 16
Returns On Capital At Align Technology (NASDAQ:ALGN) Have Stalled
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...분석 기사 • Jun 01
Is Align Technology, Inc. (NASDAQ:ALGN) Potentially Undervalued?
Let's talk about the popular Align Technology, Inc. ( NASDAQ:ALGN ). The company's shares led the NASDAQGS gainers with...Seeking Alpha • Mar 07
Align Technology: Brace Yourself, This Stock Is Undervalued
Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking AlphaSeeking Alpha • Jan 05
Align Technology: Economic Headwinds Cloud An Attractive Growth Story
Summary Align Technology shares have remained under pressure over the past year due to soft consumer demand for the company’s clear aligner products. I expect growth to accelerate to at least 5% in FY25, mainly driven by strong demand for the systems and services that are sold to doctors. Profit margins are expected to improve, following the restructuring program initiated in Q4. Despite certain key risks, I find the valuation at 20.4 times FCF compelling enough to justify a Buy rating for this dominant player in the industry. Read the full article on Seeking AlphaSeeking Alpha • Oct 27
Align Technology: A Change In Plans After Mixed Q3 Earnings
Summary Align Technology reported mixed Q3 earnings, with a beat on EPS at $2.35 but a slight miss on revenue at $977.87M. Despite challenges in the U.S. market, growth in Asia Pacific, EMEA, and Latin America, and increased Clear Aligner volume, show resilience. Align's growth drivers include product enhancements, infrastructure investments, and partnerships, with expected revenue growth of 5.29%-7.53% year-over-year from Q4 2024 to Q4 2026. Risks include premium valuation, economic factors affecting consumer spending, and foreign exchange fluctuations, but I plan to add to my position at attractive price levels. Read the full article on Seeking Alpha매출 및 비용 세부 내역
매출 및 비용 세부 내역
Align Technology가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 4,096 | 430 | 1,774 | 371 |
| 31 Dec 25 | 4,035 | 410 | 1,756 | 370 |
| 30 Sep 25 | 3,983 | 378 | 1,739 | 382 |
| 30 Jun 25 | 3,965 | 438 | 1,755 | 374 |
| 31 Mar 25 | 3,981 | 410 | 1,759 | 370 |
| 31 Dec 24 | 3,999 | 421 | 1,763 | 364 |
| 30 Sep 24 | 3,961 | 442 | 1,741 | 351 |
| 30 Jun 24 | 3,943 | 447 | 1,715 | 355 |
| 31 Mar 24 | 3,917 | 462 | 1,716 | 351 |
| 31 Dec 23 | 3,862 | 445 | 1,703 | 347 |
| 30 Sep 23 | 3,807 | 363 | 1,711 | 348 |
| 30 Jun 23 | 3,737 | 314 | 1,701 | 336 |
| 31 Mar 23 | 3,705 | 315 | 1,675 | 321 |
| 31 Dec 22 | 3,735 | 362 | 1,674 | 305 |
| 30 Sep 22 | 3,864 | 511 | 1,716 | 294 |
| 30 Jun 22 | 3,990 | 619 | 1,745 | 283 |
| 31 Mar 22 | 4,031 | 706 | 1,751 | 268 |
| 31 Dec 21 | 3,953 | 772 | 1,709 | 250 |
| 30 Sep 21 | 3,756 | 740 | 1,606 | 227 |
| 30 Jun 21 | 3,474 | 698 | 1,490 | 206 |
| 31 Mar 21 | 2,816 | 458 | 1,315 | 188 |
| 31 Dec 20 | 2,472 | 1,776 | 1,201 | 175 |
| 30 Sep 20 | 2,287 | 1,738 | 1,132 | 168 |
| 30 Jun 20 | 2,160 | 1,701 | 1,097 | 163 |
| 31 Mar 20 | 2,409 | 1,889 | 1,108 | 161 |
| 31 Dec 19 | 2,407 | 443 | 1,072 | 157 |
| 30 Sep 19 | 2,291 | 419 | 1,019 | 152 |
| 30 Jun 19 | 2,189 | 417 | 956 | 145 |
| 31 Mar 19 | 2,079 | 376 | 900 | 137 |
| 31 Dec 18 | 1,966 | 400 | 852 | 129 |
| 30 Sep 18 | 1,854 | 313 | 808 | 119 |
| 30 Jun 18 | 1,734 | 295 | 763 | 111 |
| 31 Mar 18 | 1,600 | 258 | 714 | 104 |
| 31 Dec 17 | 1,473 | 231 | 666 | 98 |
| 30 Sep 17 | 1,345 | 269 | 614 | 93 |
| 30 Jun 17 | 1,239 | 238 | 571 | 89 |
| 31 Mar 17 | 1,151 | 219 | 530 | 83 |
| 31 Dec 16 | 1,080 | 190 | 491 | 76 |
| 30 Sep 16 | 1,017 | 191 | 460 | 68 |
| 30 Jun 16 | 946 | 167 | 435 | 65 |
| 31 Mar 16 | 886 | 148 | 414 | 62 |
| 31 Dec 15 | 845 | 144 | 390 | 61 |
| 30 Sep 15 | 814 | 135 | 377 | 61 |
| 30 Jun 15 | 796 | 145 | 355 | 56 |
양질의 수익: ALGN는 $153.5M 규모의 큰 일회성 손실이 있어 31st March, 2026까지 지난 12개월 재무 결과에 영향을 미쳤습니다.
이익 마진 증가: ALGN의 현재 순 이익률 (10.5%)은 지난해 (10.3%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: ALGN의 수익은 지난 5년 동안 연평균 11.3% 감소했습니다.
성장 가속화: 지난 1년간 ALGN 의 수익 증가율(5%)은 연간 평균(-11.3%)을 초과합니다.
수익 대 산업: ALGN의 지난 1년 수익 증가율(5%)은 Medical Equipment 업계 평균(14.8%)을 능가하지 못했습니다.
자기자본이익률
높은 ROE: ALGN의 자본 수익률(10.4%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/21 14:02 |
| 종가 | 2026/05/20 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Align Technology, Inc.는 43명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Charley Jones | Barrington Research Associates, Inc. |